Faron Pharmaceuticals Oy (LON:FARN) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?

Faron Pharmaceuticals Oy (LON:FARN)’s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 181.67 ($2.32) and traded as high as GBX 183 ($2.34). Faron Pharmaceuticals Oy shares last traded at GBX 173 ($2.21), with a volume of 122,619 shares trading hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The firm has a market capitalization of £232.26 million, a P/E ratio of -4.63 and a beta of 0.36. The company’s 50 day moving average is GBX 181.67 and its 200-day moving average is GBX 186.49.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.